The establishment of a national genomic medicine centre is a key objective under the National Strategy for Accelerating Genetic and Genomic Medicine in Ireland. As a major capital project, it must proceed through the formal Capital Appraisals Process to ensure rigorous planning and financial oversight.
The timeline remains contingent upon several critical factors, including the final agreed scale of the facility, the successful conclusion of feasibility studies, and the completion and approval of preliminary costing required for the full Business Case. My Department continues to work closely with the HSE’s National Genetics and Genomics Office (NGGO) in progressing the initial planning stages as swiftly as possible.